NASDAQ:TCBP TC Biopharm (TCBP) Stock Price, News & Analysis → The Department of Defense Has a New Drone Contractor (From The Tomorrow Investor) (Ad) Free TCBP Stock Alerts $1.23 -0.22 (-15.17%) (As of 05/7/2024 ET) Add Compare Share Share Today's Range$1.06▼$1.6050-Day Range$1.04▼$1.9552-Week Range$0.85▼$21.20Volume6.48 million shsAverage Volume3.92 million shsMarket Capitalization$832,710.00P/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsFinancialsHeadlinesInsider TradesOwnershipShort InterestSocial MediaStock AnalysisChartCompetitorsFinancialsHeadlinesInsider TradesOwnershipShort InterestSocial Media Get TC Biopharm alerts: Email Address Ad Unstoppable Prosperity“Crash Insurance” For Your RetirementWhen it comes to retirement, everyone fears one thing… Outliving their retirement savings. You'll discover conservative, beginner-friendly options strategies which could help to cash flow your stock portfolio. Click here to register for free. About TC Biopharm Stock (NASDAQ:TCBP)TC Biopharm (Holdings) Plc, a clinical-stage biopharmaceutical company, focuses on the development of immunotherapy products based on its allogeneic gamma delta T cell platform. Its product pipeline includes OmnImmune, an allogeneic unmodified gamma-delta T cell therapy product under Phase 2/3 trails for the treatment of acute myeloid leukemia; and ImmuniStim, an unmodified cell therapy to treat viral infections as well as cancers. The company was founded in 2013 and is headquartered in Motherwell, the United Kingdom.Read More TCBP Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart TCBP Stock News HeadlinesMay 6, 2024 | prnewswire.comTC BioPharm Announces Exercise of Warrants for £3.1 Million Gross ProceedsMay 6, 2024 | investorplace.comWhy Is TC Biopharm (TCBP) Stock Up 51% Today?May 8, 2024 | The Tomorrow Investor (Ad)The Department of Defense Has a New Drone ContractorThe Department of Defense just granted a major advantage to a small UAV provider. Since 1998, this Nasdaq-listed company has been supplying drones for civilian, enterprise, and military purposes.May 6, 2024 | markets.businessinsider.comTC BioPharm Inks LOI To Acquire Privately-held CAR-T Therapy InnovatorMay 6, 2024 | prnewswire.comTC BioPharm Announces Execution of Second Non-Binding Letter of Intent for Acquisition, Targeting Innovative CAR-T TherapiesMay 3, 2024 | americanbankingnews.comTC Biopharm (NASDAQ:TCBP) Shares Down 2% April 6, 2024 | uk.investing.comTC BioPharm eyes expansion with CAR-NK technology LOIApril 4, 2024 | msn.comHyosung invests $1bn in green raw materials for ‘bio-spandex’May 8, 2024 | The Tomorrow Investor (Ad)The Department of Defense Has a New Drone ContractorThe Department of Defense just granted a major advantage to a small UAV provider. Since 1998, this Nasdaq-listed company has been supplying drones for civilian, enterprise, and military purposes.April 4, 2024 | marketwatch.comTC BioPharm Shares Rise 63% After Letter Intent to Buy Cancer Therapy AssetsApril 4, 2024 | investorplace.comWhy Is TC Biopharm (TCBP) Stock Up 78% Today?April 4, 2024 | markets.businessinsider.comTC BioPharm Enters Non-Binding Letter Of Intent For Acquisition Of NK Platform TechnologiesApril 4, 2024 | finance.yahoo.comTCBP Announces Execution of Non-Binding Letter of Intent for Acquisition of NK Platform TechnologiesApril 2, 2024 | prnewswire.comTCBP Increasing Treatment Capacity with Expanded Manufacturing ProcessMarch 19, 2024 | finance.yahoo.comTCBP Adjourns General Meeting Until a Later DateMarch 18, 2024 | finance.yahoo.comTCBP Announces Exercise of Series D Warrants For CashMarch 6, 2024 | msn.comBeyondSpring, enVVeno Medical, Aptorum Group among healthcare moversMarch 1, 2024 | finance.yahoo.comBryan Kobel, CEO of TCBP, Appears on Nationally Syndicated "The Big Biz Show"February 27, 2024 | finance.yahoo.com/C O R R E C T I O N -- TC BioPharm/February 27, 2024 | prnewswire.comTCBP Announces Shareholder Update Call on March 5th 2024February 22, 2024 | benzinga.comTC BioPharm (Holdings) Stock (NASDAQ:TCBP), Short Interest ReportFebruary 22, 2024 | msn.comOcugen, Community Health Systems among healthcare moversFebruary 22, 2024 | finance.yahoo.comTCBP Announces MHRA Acceptance of Amendment for ACHIEVE UK TrialFebruary 22, 2024 | prnewswire.comTCBP Announces MHRA Acceptance of Amendment for ACHIEVE UK TrialFebruary 15, 2024 | finance.yahoo.comTC BioPharm Management to Participate at Upcoming 7th CAR-TCR Summit EuropeFebruary 15, 2024 | prnewswire.comTC BioPharm Management to Participate at Upcoming 7th CAR-TCR Summit EuropeFebruary 14, 2024 | finance.yahoo.comTCBP Provides Shareholder Update and Highlights Upcoming MilestonesSee More Headlines Receive TCBP Stock News and Ratings via Email Sign-up to receive the latest news and ratings for TC Biopharm and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today5/07/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Biological products, except diagnostic Sub-IndustryN/A Current SymbolNASDAQ:TCBP CUSIPN/A CIK1872812 Webwww.tcbiopharm.com Phone44-14-1433-7557FaxN/AEmployees41Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity Ratio0.56 Current Ratio1.20 Quick Ratio1.20 Sales & Book Value Annual Sales$4.76 million Price / Sales0.17 Cash FlowN/A Price / Cash FlowN/A Book Value$4.94 per share Price / Book0.25Miscellaneous Outstanding Shares677,000Free Float677,000Market Cap$832,710.00 OptionableNot Optionable Beta0.13 (Almost) Everything You Need To Know About The EV MarketClick the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise. Get This Free Report Key ExecutivesMr. Bryan L. Kobel (Age 45)CEO & Director Mr. Martin E. Thorp (Age 72)CFO & Director Mr. Christopher CamarraExecutive Vice President of CommunicationsDr. Lauren Bor Ph.D.Head of Commercial Development DivisionKey CompetitorsAcorda TherapeuticsNASDAQ:ACORScinai ImmunotherapeuticsNASDAQ:SCNISQZ BiotechnologiesNYSE:SQZAcorda TherapeuticsNASDAQ:ACORQWindtree TherapeuticsNASDAQ:WINTView All CompetitorsInstitutional OwnershipArmistice Capital LLCSold 223,500 shares on 2/13/2024Ownership: 10.882%View All Institutional Transactions TCBP Stock Analysis - Frequently Asked Questions How have TCBP shares performed in 2024? TC Biopharm's stock was trading at $3.17 at the beginning of 2024. Since then, TCBP shares have decreased by 61.2% and is now trading at $1.23. View the best growth stocks for 2024 here. Are investors shorting TC Biopharm? TC Biopharm saw a drop in short interest in the month of March. As of March 31st, there was short interest totaling 204,500 shares, a drop of 68.0% from the March 15th total of 638,700 shares. Based on an average trading volume of 4,520,000 shares, the days-to-cover ratio is currently 0.0 days. View TC Biopharm's Short Interest. When did TC Biopharm's stock split? TC Biopharm's stock reverse split before market open on Friday, December 15th 2023. The 1-20 reverse split was announced on Friday, December 15th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Friday, December 15th 2023. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split. When did TC Biopharm IPO? TC Biopharm (TCBP) raised $17 million in an initial public offering (IPO) on Friday, February 11th 2022. The company issued 4,100,000 shares at a price of $4.25 per share. EF Hutton acted as the underwriter for the IPO. How do I buy shares of TC Biopharm? Shares of TCBP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:TCBP) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldShocking: One AI startup's revenue could surge 4,735%Manward PressThe Department of Defense Has a New Drone ContractorThe Tomorrow InvestorAI “wealth window” is closing June 25thParadigm PressStock-Picking AI Predicts #1 Stock of 2024AltimetryGold Set to EXPLODE!Gold Safe ExchangeThe #1 lithium battery stock to have on your radar in 2024!Smallcaps Daily Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TC Biopharm (Holdings) Plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
